383 related articles for article (PubMed ID: 26923341)
21. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
Minn AY; Hsu A; La T; Kunz P; Fisher GA; Ford JM; Norton JA; Visser B; Goodman KA; Koong AC; Chang DT
Cancer; 2010 Aug; 116(16):3943-52. PubMed ID: 20564136
[TBL] [Abstract][Full Text] [Related]
22. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
[TBL] [Abstract][Full Text] [Related]
23. Early morbidity and dose-volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques.
Seppenwoolde Y; Majercakova K; Buschmann M; Dörr E; Sturdza AE; Schmid MP; Pötter R; Georg D
Strahlenther Onkol; 2021 Jun; 197(6):505-519. PubMed ID: 33929558
[TBL] [Abstract][Full Text] [Related]
24. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer.
Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA
Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605
[TBL] [Abstract][Full Text] [Related]
25. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
26. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
[TBL] [Abstract][Full Text] [Related]
27. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.
Chen MF; Tseng CJ; Tseng CC; Kuo YC; Yu CY; Chen WC
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1438-44. PubMed ID: 17394944
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of intensity-modulated radiotherapy and standard radiation field with concurrent chemotherapy for local advanced cervical cancer.
Yu C; Zhu W; Ji Y; Guo J; Pan P; Han J; Zhou X
Eur J Gynaecol Oncol; 2015; 36(3):278-82. PubMed ID: 26189253
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy.
Tozzi A; Cozzi L; Iftode C; Ascolese A; Campisi MC; Clerici E; Comito T; De Rose F; Fogliata A; Franzese C; Mancosu P; Navarria P; Tomatis S; Villa E; Scorsetti M
BMC Cancer; 2014 Nov; 14():833. PubMed ID: 25403766
[TBL] [Abstract][Full Text] [Related]
31. Reduced Risk of Lymphedema With Intensity-modulated Radiation Therapy Compared With 3-dimensional Conformal Radiation Therapy in Patients With Cervical Cancer Who Received Postoperative Pelvic Radiation Therapy.
Uezono H; Tsujino K; Miyazaki S; Marudai M; Bessyo R; Takabayashi H; Yamaguchi S; Ota Y
Am J Clin Oncol; 2023 Aug; 46(8):346-352. PubMed ID: 37231540
[TBL] [Abstract][Full Text] [Related]
32. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
33. Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy.
Sutani S; Ohashi T; Sakayori M; Kaneda T; Yamashita S; Momma T; Hanada T; Shiraishi Y; Fukada J; Oya M; Shigematsu N
Radiother Oncol; 2015 Nov; 117(2):270-6. PubMed ID: 26318662
[TBL] [Abstract][Full Text] [Related]
34. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer.
Sharma NK; Li T; Chen DY; Pollack A; Horwitz EM; Buyyounouski MK
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):437-44. PubMed ID: 21050673
[TBL] [Abstract][Full Text] [Related]
36. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
[TBL] [Abstract][Full Text] [Related]
37. Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy.
Onal C; Yuce Sari S; Yavas G; Oymak E; Birgi SD; Yigit E; Guler OC; Gultekin M; Akyurek S; Yildiz F
Acta Oncol; 2021 Sep; 60(9):1154-1160. PubMed ID: 33999750
[TBL] [Abstract][Full Text] [Related]
38. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587
[TBL] [Abstract][Full Text] [Related]
39. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
[TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis.
Lin Y; Chen K; Lu Z; Zhao L; Tao Y; Ouyang Y; Cao X
Radiat Oncol; 2018 Sep; 13(1):177. PubMed ID: 30217165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
